Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular redox-sensitive proteins and glutathione-dependent pathways represent a broad biological system rather than a single molecular entity, comprising a network of enzymes and signaling molecules that maintain intracellular redox homeostasis. The glutathione (GSH) system is a cornerstone of this network, utilizing enzymes such as glutathione peroxidase (GPX) and glutathione S-transferase (GST) to neutralize reactive oxygen species (ROS) and detoxify xenobiotics (PubChem, CID 124886). Redox-sensitive proteins, particularly the Nrf2 (NFE2L2) transcription factor and its regulator Keap1, serve as sensors that activate the antioxidant response element (ARE) to induce the expression of protective genes (PubMed, PMID 29033367). Dysregulation of these pathways is a hallmark of various diseases; for instance, cancer cells often upregulate GSH to resist chemotherapy, while impaired redox signaling contributes to neurodegeneration and cardiovascular disease (NIH, PMC4684116). Therapeutic interventions include Nrf2 activators like dimethyl fumarate for multiple sclerosis and glutathione-depleting agents like buthionine sulfoximine (BSO) for cancer sensitization (PubMed, PMID 22503473).
Modulation of the Nrf2-Keap1 pathway to induce antioxidant gene expression, replenishment of intracellular glutathione pools, or inhibition of glutathione synthesis and utilization enzymes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular redox-sensitive proteins and glutathione-dependent pathways.